Correlation between RPPA expression and clinical features
Colon/Rectal Adenocarcinoma (Primary solid tumor)
21 April 2013  |  analyses__2013_04_21
Maintainer Information
Citation Information
doi:10.7908/C1FJ2DQR
Maintained by Juok Cho (Broad Institute)
Cite as Broad Institute TCGA Genome Data Analysis Center (2013): Colon/Rectal Adenocarcinoma (Primary solid tumor cohort) - 21 April 2013: Correlation between RPPA expression and clinical features. Broad Institute of MIT and Harvard. doi:10.7908/C1FJ2DQR
Overview
Introduction

This pipeline uses various statistical tests to identify RPPAs whose expression levels correlated to selected clinical features.

Summary

Testing the association between 171 genes and 12 clinical features across 461 samples, statistically thresholded by Q value < 0.05, 7 clinical features related to at least one genes.

  • 71 genes correlated to 'PRIMARY.SITE.OF.DISEASE'.

    • CHEK1|CHK1_PS345-R-C ,  BECN1|BECLIN-G-V ,  MRE11A|MRE11-R-C ,  STK11|LKB1-M-NA ,  BIRC2|CIAP-R-V ,  ...

  • 68 genes correlated to 'HISTOLOGICAL.TYPE'.

    • CHEK1|CHK1_PS345-R-C ,  ERBB3|HER3_PY1298-R-C ,  MRE11A|MRE11-R-C ,  STK11|LKB1-M-NA ,  MET|C-MET_PY1235-R-C ,  ...

  • 1 gene correlated to 'PATHOLOGY.T'.

    • PTGS2|COX-2-R-C

  • 7 genes correlated to 'PATHOLOGY.N'.

    • EIF4E|EIF4E-R-V ,  IRS1|IRS1-R-V ,  CASP7|CASPASE-7_CLEAVEDD198-R-C ,  MYC|C-MYC-R-C ,  PXN|PAXILLIN-R-V ,  ...

  • 10 genes correlated to 'TUMOR.STAGE'.

    • IRS1|IRS1-R-V ,  CASP7|CASPASE-7_CLEAVEDD198-R-C ,  EIF4E|EIF4E-R-V ,  GAB2|GAB2-R-V ,  CCNE1|CYCLIN_E1-M-V ,  ...

  • 1 gene correlated to 'COMPLETENESS.OF.RESECTION'.

    • PIK3CA|PI3K-P110-ALPHA-R-C

  • 7 genes correlated to 'NUMBER.OF.LYMPH.NODES'.

    • IRS1|IRS1-R-V ,  EIF4E|EIF4E-R-V ,  PXN|PAXILLIN-R-V ,  GAB2|GAB2-R-V ,  CASP7|CASPASE-7_CLEAVEDD198-R-C ,  ...

  • No genes correlated to 'Time to Death', 'AGE', 'GENDER', 'PATHOLOGICSPREAD(M)', and 'RADIATIONS.RADIATION.REGIMENINDICATION'.

Results
Overview of the results

Complete statistical result table is provided in Supplement Table 1

Table 1.  Get Full Table This table shows the clinical features, statistical methods used, and the number of genes that are significantly associated with each clinical feature at Q value < 0.05.

Clinical feature Statistical test Significant genes Associated with                 Associated with
Time to Death Cox regression test   N=0        
AGE Spearman correlation test   N=0        
PRIMARY SITE OF DISEASE t test N=71 rectum N=0 colon N=71
GENDER t test   N=0        
HISTOLOGICAL TYPE ANOVA test N=68        
PATHOLOGY T Spearman correlation test N=1 higher pT N=1 lower pT N=0
PATHOLOGY N Spearman correlation test N=7 higher pN N=3 lower pN N=4
PATHOLOGICSPREAD(M) ANOVA test   N=0        
TUMOR STAGE Spearman correlation test N=10 higher stage N=4 lower stage N=6
RADIATIONS RADIATION REGIMENINDICATION t test   N=0        
COMPLETENESS OF RESECTION ANOVA test N=1        
NUMBER OF LYMPH NODES Spearman correlation test N=7 higher number.of.lymph.nodes N=3 lower number.of.lymph.nodes N=4
Clinical variable #1: 'Time to Death'

No gene related to 'Time to Death'.

Table S1.  Basic characteristics of clinical feature: 'Time to Death'

Time to Death Duration (Months) 0.1-135.5 (median=7.3)
  censored N = 317
  death N = 51
     
  Significant markers N = 0
Clinical variable #2: 'AGE'

No gene related to 'AGE'.

Table S2.  Basic characteristics of clinical feature: 'AGE'

AGE Mean (SD) 66.77 (13)
  Significant markers N = 0
Clinical variable #3: 'PRIMARY.SITE.OF.DISEASE'

71 genes related to 'PRIMARY.SITE.OF.DISEASE'.

Table S3.  Basic characteristics of clinical feature: 'PRIMARY.SITE.OF.DISEASE'

PRIMARY.SITE.OF.DISEASE Labels N
  COLON 331
  RECTUM 130
     
  Significant markers N = 71
  Higher in RECTUM 0
  Higher in COLON 71
List of top 10 genes differentially expressed by 'PRIMARY.SITE.OF.DISEASE'

Table S4.  Get Full Table List of top 10 genes differentially expressed by 'PRIMARY.SITE.OF.DISEASE'

T(pos if higher in 'RECTUM') ttestP Q AUC
CHEK1|CHK1_PS345-R-C -10.37 1.446e-21 2.47e-19 0.7802
BECN1|BECLIN-G-V -8.94 5.005e-17 8.51e-15 0.7512
MRE11A|MRE11-R-C -8.73 3.324e-16 5.62e-14 0.7655
STK11|LKB1-M-NA -8.76 4.033e-16 6.78e-14 0.755
BIRC2|CIAP-R-V -8.5 8.439e-16 1.41e-13 0.7421
XIAP|XIAP-R-C -8.31 4.718e-15 7.83e-13 0.7343
ERBB3|HER3_PY1298-R-C -8.36 9.841e-15 1.62e-12 0.7787
BID|BID-R-C -8.16 1.271e-14 2.09e-12 0.7227
AR|AR-R-V -7.9 4.786e-14 7.8e-12 0.7217
CDKN1B|P27_PT157-R-C -7.84 5.387e-14 8.73e-12 0.7387

Figure S1.  Get High-res Image As an example, this figure shows the association of CHEK1|CHK1_PS345-R-C to 'PRIMARY.SITE.OF.DISEASE'. P value = 1.45e-21 with T-test analysis.

Clinical variable #4: 'GENDER'

No gene related to 'GENDER'.

Table S5.  Basic characteristics of clinical feature: 'GENDER'

GENDER Labels N
  FEMALE 216
  MALE 245
     
  Significant markers N = 0
Clinical variable #5: 'HISTOLOGICAL.TYPE'

68 genes related to 'HISTOLOGICAL.TYPE'.

Table S6.  Basic characteristics of clinical feature: 'HISTOLOGICAL.TYPE'

HISTOLOGICAL.TYPE Labels N
  COLON ADENOCARCINOMA 290
  COLON MUCINOUS ADENOCARCINOMA 40
  RECTAL ADENOCARCINOMA 117
  RECTAL MUCINOUS ADENOCARCINOMA 10
     
  Significant markers N = 68
List of top 10 genes differentially expressed by 'HISTOLOGICAL.TYPE'

Table S7.  Get Full Table List of top 10 genes differentially expressed by 'HISTOLOGICAL.TYPE'

ANOVA_P Q
CHEK1|CHK1_PS345-R-C 5.305e-18 9.07e-16
ERBB3|HER3_PY1298-R-C 7.133e-18 1.21e-15
MRE11A|MRE11-R-C 2.247e-17 3.8e-15
STK11|LKB1-M-NA 2.931e-16 4.92e-14
MET|C-MET_PY1235-R-C 2.249e-14 3.76e-12
XIAP|XIAP-R-C 2.667e-14 4.43e-12
AR|AR-R-V 5.236e-14 8.64e-12
EGFR|EGFR_PY1173-R-C 6.744e-14 1.11e-11
BECN1|BECLIN-G-V 2.185e-13 3.56e-11
BID|BID-R-C 3.411e-13 5.53e-11

Figure S2.  Get High-res Image As an example, this figure shows the association of CHEK1|CHK1_PS345-R-C to 'HISTOLOGICAL.TYPE'. P value = 5.3e-18 with ANOVA analysis.

Clinical variable #6: 'PATHOLOGY.T'

One gene related to 'PATHOLOGY.T'.

Table S8.  Basic characteristics of clinical feature: 'PATHOLOGY.T'

PATHOLOGY.T Mean (SD) 2.89 (0.6)
  N
  T0 1
  T1 10
  T2 76
  T3 323
  T4 47
     
  Significant markers N = 1
  pos. correlated 1
  neg. correlated 0
List of one gene significantly correlated to 'PATHOLOGY.T' by Spearman correlation test

Table S9.  Get Full Table List of one gene significantly correlated to 'PATHOLOGY.T' by Spearman correlation test

SpearmanCorr corrP Q
PTGS2|COX-2-R-C 0.1799 0.0001101 0.0188

Figure S3.  Get High-res Image As an example, this figure shows the association of PTGS2|COX-2-R-C to 'PATHOLOGY.T'. P value = 0.00011 with Spearman correlation analysis.

Clinical variable #7: 'PATHOLOGY.N'

7 genes related to 'PATHOLOGY.N'.

Table S10.  Basic characteristics of clinical feature: 'PATHOLOGY.N'

PATHOLOGY.N Mean (SD) 0.61 (0.77)
  N
  N0 260
  N1 117
  N2 80
     
  Significant markers N = 7
  pos. correlated 3
  neg. correlated 4
List of 7 genes significantly correlated to 'PATHOLOGY.N' by Spearman correlation test

Table S11.  Get Full Table List of 7 genes significantly correlated to 'PATHOLOGY.N' by Spearman correlation test

SpearmanCorr corrP Q
EIF4E|EIF4E-R-V -0.194 2.984e-05 0.0051
IRS1|IRS1-R-V 0.1916 3.744e-05 0.00636
CASP7|CASPASE-7_CLEAVEDD198-R-C -0.1886 4.987e-05 0.00843
MYC|C-MYC-R-C 0.1735 0.0001936 0.0325
PXN|PAXILLIN-R-V 0.1728 0.0002054 0.0343
BAX|BAX-R-V -0.1703 0.0002551 0.0423
BCL2|BCL-2-R-NA -0.1688 0.0002882 0.0475

Figure S4.  Get High-res Image As an example, this figure shows the association of EIF4E|EIF4E-R-V to 'PATHOLOGY.N'. P value = 2.98e-05 with Spearman correlation analysis.

Clinical variable #8: 'PATHOLOGICSPREAD(M)'

No gene related to 'PATHOLOGICSPREAD(M)'.

Table S12.  Basic characteristics of clinical feature: 'PATHOLOGICSPREAD(M)'

PATHOLOGICSPREAD(M) Labels N
  M0 356
  M1 54
  M1A 8
  M1B 1
  MX 36
     
  Significant markers N = 0
Clinical variable #9: 'TUMOR.STAGE'

10 genes related to 'TUMOR.STAGE'.

Table S13.  Basic characteristics of clinical feature: 'TUMOR.STAGE'

TUMOR.STAGE Mean (SD) 2.44 (0.91)
  N
  Stage 1 68
  Stage 2 175
  Stage 3 140
  Stage 4 62
     
  Significant markers N = 10
  pos. correlated 4
  neg. correlated 6
List of 10 genes significantly correlated to 'TUMOR.STAGE' by Spearman correlation test

Table S14.  Get Full Table List of 10 genes significantly correlated to 'TUMOR.STAGE' by Spearman correlation test

SpearmanCorr corrP Q
IRS1|IRS1-R-V 0.196 3.132e-05 0.00536
CASP7|CASPASE-7_CLEAVEDD198-R-C -0.1865 7.536e-05 0.0128
EIF4E|EIF4E-R-V -0.1813 0.0001197 0.0202
GAB2|GAB2-R-V 0.1775 0.0001681 0.0282
CCNE1|CYCLIN_E1-M-V -0.1752 0.0002031 0.0339
BAX|BAX-R-V -0.1744 0.0002185 0.0363
YBX1|YB-1-R-V 0.1718 0.0002714 0.0448
BCL2|BCL-2-R-NA -0.1714 0.0002808 0.046
MAPK14|P38_MAPK-R-C -0.1708 0.0002941 0.0479
MYC|C-MYC-R-C 0.1704 0.0003045 0.0493

Figure S5.  Get High-res Image As an example, this figure shows the association of IRS1|IRS1-R-V to 'TUMOR.STAGE'. P value = 3.13e-05 with Spearman correlation analysis.

Clinical variable #10: 'RADIATIONS.RADIATION.REGIMENINDICATION'

No gene related to 'RADIATIONS.RADIATION.REGIMENINDICATION'.

Table S15.  Basic characteristics of clinical feature: 'RADIATIONS.RADIATION.REGIMENINDICATION'

RADIATIONS.RADIATION.REGIMENINDICATION Labels N
  NO 8
  YES 453
     
  Significant markers N = 0
Clinical variable #11: 'COMPLETENESS.OF.RESECTION'

One gene related to 'COMPLETENESS.OF.RESECTION'.

Table S16.  Basic characteristics of clinical feature: 'COMPLETENESS.OF.RESECTION'

COMPLETENESS.OF.RESECTION Labels N
  R0 336
  R1 2
  R2 28
  RX 18
     
  Significant markers N = 1
List of one gene differentially expressed by 'COMPLETENESS.OF.RESECTION'

Table S17.  Get Full Table List of one gene differentially expressed by 'COMPLETENESS.OF.RESECTION'

ANOVA_P Q
PIK3CA|PI3K-P110-ALPHA-R-C 0.0001664 0.0284

Figure S6.  Get High-res Image As an example, this figure shows the association of PIK3CA|PI3K-P110-ALPHA-R-C to 'COMPLETENESS.OF.RESECTION'. P value = 0.000166 with ANOVA analysis.

Clinical variable #12: 'NUMBER.OF.LYMPH.NODES'

7 genes related to 'NUMBER.OF.LYMPH.NODES'.

Table S18.  Basic characteristics of clinical feature: 'NUMBER.OF.LYMPH.NODES'

NUMBER.OF.LYMPH.NODES Mean (SD) 2.11 (4.6)
  Significant markers N = 7
  pos. correlated 3
  neg. correlated 4
List of 7 genes significantly correlated to 'NUMBER.OF.LYMPH.NODES' by Spearman correlation test

Table S19.  Get Full Table List of 7 genes significantly correlated to 'NUMBER.OF.LYMPH.NODES' by Spearman correlation test

SpearmanCorr corrP Q
IRS1|IRS1-R-V 0.2289 1.489e-06 0.000255
EIF4E|EIF4E-R-V -0.2094 1.116e-05 0.0019
PXN|PAXILLIN-R-V 0.202 2.289e-05 0.00387
GAB2|GAB2-R-V 0.2013 2.447e-05 0.00411
CASP7|CASPASE-7_CLEAVEDD198-R-C -0.1943 4.691e-05 0.00783
XRCC1|XRCC1-R-C -0.1832 0.0001258 0.0209
BAX|BAX-R-V -0.1829 0.0001298 0.0214

Figure S7.  Get High-res Image As an example, this figure shows the association of IRS1|IRS1-R-V to 'NUMBER.OF.LYMPH.NODES'. P value = 1.49e-06 with Spearman correlation analysis. The straight line presents the best linear regression.

Methods & Data
Input

  • Expresson data file = COADREAD-TP.rppa.txt

  • Clinical data file = COADREAD-TP.clin.merged.picked.txt

  • Number of patients = 461

  • Number of genes = 171

  • Number of clinical features = 12

Survival analysis

For survival clinical features, Wald's test in univariate Cox regression analysis with proportional hazards model (Andersen and Gill 1982) was used to estimate the P values using the 'coxph' function in R. Kaplan-Meier survival curves were plot using the four quartile subgroups of patients based on expression levels

Correlation analysis

For continuous numerical clinical features, Spearman's rank correlation coefficients (Spearman 1904) and two-tailed P values were estimated using 'cor.test' function in R

Student's t-test analysis

For two-class clinical features, two-tailed Student's t test with unequal variance (Lehmann and Romano 2005) was applied to compare the log2-expression levels between the two clinical classes using 't.test' function in R

ANOVA analysis

For multi-class clinical features (ordinal or nominal), one-way analysis of variance (Howell 2002) was applied to compare the log2-expression levels between different clinical classes using 'anova' function in R

Q value calculation

For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.

Download Results

This is an experimental feature. The full results of the analysis summarized in this report can be downloaded from the TCGA Data Coordination Center.

References
[1] Andersen and Gill, Cox's regression model for counting processes, a large sample study, Annals of Statistics 10(4):1100-1120 (1982)
[2] Spearman, C, The proof and measurement of association between two things, Amer. J. Psychol 15:72-101 (1904)
[3] Lehmann and Romano, Testing Statistical Hypotheses (3E ed.), New York: Springer. ISBN 0387988645 (2005)
[4] Howell, D, Statistical Methods for Psychology. (5th ed.), Duxbury Press:324-5 (2002)
[5] Benjamini and Hochberg, Controlling the false discovery rate: a practical and powerful approach to multiple testing, Journal of the Royal Statistical Society Series B 59:289-300 (1995)
Copyright © 2013 Broad Institute TCGA GDAC as part of the TCGA Research Network. All rights reserved.
Made with Nozzle